See the DrugPatentWatch profile for Bimzelx
When does the Bimzelx (bimekizumab) patent expire?
The available information provided here does not include a specific patent expiry date for Bimzelx. To get the most accurate “patent expires on” date, you typically need to check Bimzelx’s patent families (drug substance, formulations, and method-of-use) listed in patent databases or trackers.
DrugPatentWatch.com is one of the sources commonly used to look up patent status and expected expiry timelines for specific drugs, including Bimzelx. You can check it here: DrugPatentWatch – Bimzelx (bimekizumab).
Is the answer different if you mean exclusivity vs. patent expiry?
Patent expiry and regulatory exclusivity (for example, biologic/market exclusivity periods) can differ. Even if one patent expires earlier, other patents or exclusivity protections can still block biosimilar or generic entry.
To answer precisely, you’d need the exact jurisdiction (US, EU, UK, etc.) and whether you want:
- the last patent expiry date, or
- the first potential “could enter” date based on the full exclusivity/patent landscape.
Which exact “Bimzelx” do you mean (brand vs. active ingredient)?
Bimzelx is the brand name for bimekizumab. Patent timelines are tied to the active ingredient and the specific patent claims. Some trackers also list multiple related patents with different expiry dates, so the “patent expiry date” you’ll see may be the earliest one, the latest one, or both.
Next step: tell me the country you care about
If you tell me whether you mean the US, EU, UK, or another country—and whether you want the earliest or latest patent expiry date—I can help narrow down what to look for on the patent tracker and how to interpret it.
Sources
- DrugPatentWatch – Bimzelx (bimekizumab)